References:
1. Hemila H, Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev. 2013 Jan 31; (1): CD000980.
2. Douglas RM, Chalker EB, Treacy B. Vitamin C for preventing and treating the common cold. (updated). Cochrane Database Syst Rev. 2014 Oct 18;(4):CD00980.
3. Jensen GS, Patterson KM, Barnes J, Schauss AG, Beaman R, Reeves SG, Robinson LE. A Double-Blind Placebo-Controlled, Randomized Pilot Study: Consumption of a High-Metabolite Immunogen from Yeast Culture has Beneficial Effects on Erythrocyte Health and Mucosal Immune Protection in Healthy Subjects. The Open Nutrition Journal. 2008;2:68-75.
4. Moyad MA, Robinson LE, Zawada Jr. ET, Kittelsrud JM, Chen DG, Reeves SG, Weaver SE. Effects of a modified yeast supplement on cold/flu symptoms.. Urol Nurs. 2008 Feb;28(1):50-5.
5. Moyad MA, Robinson LE, Zawada ET, Kittelsrud J, Chen DG, Reeves SG, Weaver S. Immunogenic Yeast-Based Fermentate for Cold/Flu-like Symptoms in Nonvaccinated Individuals. J Altern Complement Med. 2010 Feb 1;16(2):213-218.
6. Moyad MA, Robinson LE, Kittelsrud JM, Reeves SG, Weaver SE, Guzman AI, Bubak ME. Immunogenic yeast-based fermentation product reduces allergic rhinitis-induced nasal congestion: a randomized, double-blind, placebo-controlled trial. Adv Ther. 2009 Aug;26(8):795-804.
7. Jensen GS, Redman KA, Benson KF, Carter SG, Mitzner MA, Reeves S, Robinson L. Antioxidant bioavailability and rapid immune-modulating effects after consumption of a single acute dose of a high-metabolite yeast immunogen: results of a placebo-controlled double-blinded crossover pilot study. J Med Food. 2001 Sep;14(9):1002-10. 8. Punheiro I, Robinson L, Verhelst A, Marzorati M, Winkens B, Van den Abbeele P, Possemiers S. A yeast fermentate improves gastrointestinal discomfort and constipation by modulation of the gut microbiome: results from a randomized double-blind placebo-controlled pilot trial. BMC Complement Altern Med. 2017 Sep 4;17(1):441.
9. 6. Jensen, G. S.; Carter, S. G.; Reeves, S. G.; Robinson, L. E.; Benson, K. F., Anti-Inflammatory Properties of a Dried Fermentate In Vitro and In Vivo. J Med Food 2014. 10. Li Y, Yao J, Han C, Yang J, Chaudhry MT, Wang S, Lui H, Yin Y. Quercetin, Inflammation, and Immunity. Nutrients. 2016 Mar;8(3):167.
11. Mlcek J, Jurikova T, Skrovankova S, Sochor J. Quercetin and Its Anti-Allergic Immune Response. Molecules. 2016 May;21(5):632.
12. Yu YL, Cheng WC, OuYang CN, Fu E, Chu CL. Immunosuppresive Effect of Quercetin on Dendritic Cell Activation and Function. The Journal of Immunology. 2010;184:6815-6821.
13. Wong G, He S, Siragam V, Br Y, Mbikay M, Chretien M, Qiu X. Antiviral activity of quercetin 3-β-O-D-glucoside against Zika virus infection. Virol Sin. 2017 Dec;32(6):545-547.
14. Gaudry A, Bos S, Viranaicken W, Roche M, Kerjbich-Trotot P, Gadea G, Depres P, El-Kalamouni C. The Flavonoid Isoquercitrin Precludes Initiation of Zika Virus Infection in Human Cells. Int J Mol Sci. 2018;19(4):1093.
15. Munjal A, Khandia R, Dhama K, Sachan S, Karthik K, Tiwari R, Malik YS, Kumar D, Singh RK, Iqbal HMN, Joshi SK. Advances in Developing Therapies to Combat Zika Virus: Current Knowledge and Future Perspectives. Microbiol Aug 3 2017.
16. Lima CS, Caruso IP, Araujo GC, Hirokubo L, Lacove R, Falcon M, Desideri A, Oliveira J, Regsaini LO, Souza FP, Toledo KA. Quercetin pentaacetate inhibits in vitro human respiratory syncytial virus adhesion. Virus Research Jan 2020;276:197805.
17.Qiu X, Kroeker A, He S, Kozak R, Audet J, Mbikay M, Chretien M. Prophylactic Efficacy of Quercetin 3-β-O-d-Glucoside against Ebola Virus Infection. Antimicrob Agents Chemother. 2016 Sep;60(9):5182-5188.
18. Farazuddin M, Mishra R, Jing Y, Srivastava V, Comstock AT, Sajian US. Quercetin prevents rhinovirus-induced progression of lung disease in mice with COPD phenotype. PLoS One. 2018;13(7):e0199612.
19. Wu W, Li R, Li X, Ho J, Jiang S, Liu S, Yang J. Quercetin as an Antiviral Agent Inhibits Influenza A virus (IAV) Entry. Viruses. 2016 Jan;8(1):6.
20. Hosseinzade A, Sadeghi O, Biregani AN, Soukhtehzarl S, Brandt GS, Esmaillzadeh A. Immunomodulatory Effects of Flavonoids: Possible Induction of T CD4+ Regulatory Cells Through Suppression of MTOR Pathway Signaling Activitiy. Front Immunol. 2019 Jan 31.
21. Aranow C. Vitamin D and the Immune System. J Investig Med. 2011 Aug;59(6):881-886.
22. Prieti B, Treiber G, Pieber TR, Amrein K. Vitamin D and Immune Function. Nutrients. 2013 Jul;5(7):2502-2521.
23. Medrano M, Carrillo-Cruz E, Montero I, Perez-Simon JA. Vitamin D: Effect on Haematopoiess and Immune System and Clinical Applications. Int J Mol Sci. 2018 Sep;19(9):2663.
24. Braun M, Schneider B, Beuth HJ. Therapeutic use efficiency and safety of the proteolytic pineapple enzyme Bromelain-POS in children with acute sinusitis in Germany. In vivo. 2005;19:417-421.
25. Rathnavelu V, Alitheen NB, Sohila S, Kanagesan S, Ramesh R. Potential role of bromelain in clinical therapeutic applications. Biomed Rep. 12016 Sep;5(3):283-288. 26. Engwerda CR, Andrew D, Ladhams A, Mynott TL. Bromelain Modulates T Cell and B Cell Immune Responses in vitro and in vivo. Cellular Immunology. 2001 May;210(1):66-75.
27. Nuttner L, et al. Efficacy and tolerability of bromelain in patients with chronic rhinosinusitis—a pilot study. B-ENT. 2013;9(3):217-25. 28. Guo R, Canter PH, Ernst E. Herbal medicines for the treatment of rhinosinusitis: a systematic review. Otolaryngol Head Neck Surg. 22006 Oct;35(4):496-506.
28. https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/quercetin
29.Ginde AA, Mansbach JM, Camargo CA., Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2009;169(4):384–90.
30.Laaksi I, et al. An association of serum vitamin D concentrations < 40 nmol/L with acute respiratory tract infection in young Finnish men. Am J Clin Nutr. 2007;86(3):714–7.